Anika Therapeutics (ANIK) Operating Leases (2019 - 2026)
Anika Therapeutics (ANIK) posted quarterly Operating Leases of $23.3 million for Q2 2026, up 0.61% year-over-year from $23.2 million in Q2 2025, and down 2.01% quarter-over-quarter from $23.8 million in Q1 2026.
Anika Therapeutics (ANIK) Operating Leases (2019 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Operating Leases for 8 consecutive years, with $23.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Leases rose 0.61% year-over-year to $23.3 million; the TTM figure through Jun 2026 stood at $23.3 million (up 0.61% YoY), while the FY2025 annual figure was $24.2 million, up 0.76% from the prior year.
- Operating Leases retreated to $23.3 million in Q2 2026 per ANIK's latest filing, from $23.8 million in the prior quarter.
- Across five years, Operating Leases topped out at $29.7 million in Q2 2022 and bottomed at $18.8 million in Q1 2022.
- Historically, Operating Leases has averaged $25.4 million across 5 years, with a median of $25.5 million in 2024.
- Annual changes were most pronounced in 2023 — Operating Leases surged 50.27% — and 2025, when it decreased 10.56%.
- Anika Therapeutics' Operating Leases stood at $28.8 million in 2022, then dropped by 10.07% to $25.9 million in 2023, then dropped by 7.34% to $24.0 million in 2024, then gained by 0.76% to $24.2 million in 2025, then declined by 3.64% to $23.3 million in 2026.
- Business Quant data shows ANIK's Operating Leases at $23.3 million in Q2 2026, $23.8 million in Q1 2026, and $24.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Anika Therapeutics | 285.26 Mn | 246.85 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.32 Mn |
| Mar 31, 2026 | 23.79 Mn |
| Dec 31, 2025 | 24.20 Mn |
| Sep 30, 2025 | 22.78 Mn |
| Jun 30, 2025 | 23.17 Mn |
| Mar 31, 2025 | 23.56 Mn |
| Dec 31, 2024 | 24.01 Mn |
| Sep 30, 2024 | 25.24 Mn |
| Jun 30, 2024 | 25.79 Mn |
| Mar 31, 2024 | 26.34 Mn |
| Dec 31, 2023 | 25.92 Mn |
| Sep 30, 2023 | 27.25 Mn |
| Jun 30, 2023 | 27.78 Mn |
| Mar 31, 2023 | 28.28 Mn |
| Dec 31, 2022 | 28.82 Mn |
| Sep 30, 2022 | 29.18 Mn |
| Jun 30, 2022 | 29.73 Mn |
| Mar 31, 2022 | 18.82 Mn |
| Dec 31, 2021 | 19.24 Mn |
| Sep 30, 2021 | 19.64 Mn |